Medical Providers

Provides clinical tips and advice about basic induction and dosing, complications of induction, transfer of patients from methadone to buprenorphine, maintenance dosage, tapering/discontinuation, and medically supervised withdrawal (detoxification).

Provides a list of free materials, resources, services, and funding streams available to Arizona organizations working on substance use prevention, intervention, and treatment.

Equips healthcare providers, communities, and local governments with material to develop practices and policies to help prevent opioid-related overdoses and deaths. Addresses issues for healthcare providers, first responders, treatment providers, and those recovering from opioid overdose.

Includes information for healthcare professionals, professional and patient organizations, and community groups, including tips for getting started, fact sheets on the requirements for providing chronic care management in practices, and educational materials to share with patients.

Addresses NAS, including maternal risk factors during pregnancy, social risk factors, assessment, and treatment.

Includes resources for hospitals and health systems to share with clinicians and patients and to enhance partnerships within their communities.

Provides guidance to physicians and pharmacists on buprenorphine regulatory requirements, prescribing, dispensing, and safety recommendations and additional information to improve decision making and promote beneficial outcomes.

Informs prescribers and pharmacists about prescription opioids diverted for nonmedical use, opioid regulatory requirements, value of participating in State-managed prescription drug monitoring programs, risk evaluation and mitigation strategies, and prescriber tactics that may reduce the likelihood of diversion.

Provides resources for clinicians interested in initiating buprenorphine treatment in emergency department settings.

Provides an overview of how organizations can use NIATx practices and tools to implement or improve a buprenorphine treatment program.